AnandRathi

Piramal Pharma Ltd Fundamental Analysis

Last Updated Date: 16 Oct 2026
₹197.60
+3.30 (+1.70%)

Piramal Pharma Ltd (Piramal Pharma) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹26,307 crore.

Piramal Pharma Ltd Overview

Market cap₹26,307 Crs
Volume78,819
Prev. Close₹194.30
Year range₹132.50 - ₹231.85
ISININE0DK501011

Piramal Pharma Ltd Fundamentals

ROCE(TTM)11.75%
P/E Ratio (TTM)37.57
P/B Ratio3.23
Debt to Equity0.10
ROE9.51%
EPS (TTM)5.82
Dividend Yield0.00%
Book Value61.18
Profit Margin15.69%
Operating Margin9.17%

Piramal Pharma Ltd Historical Performance

1 Month Return-2.35%
6 Month Return34.01%
3 Year Return103.71%
3 Month Return13.08%
1 Year Return1.70%
5 Year Return-

Piramal Pharma Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research